首页 正文

Soluble guanylate cyclase modulators-a novel therapeutic approach for diabetic kidney disease

{{output}}
Diabetic kidney disease (DKD) is a common complication, affecting approximately 40% of patients with diabetes and imposing substantial health and economic burdens worldwide. As DKD prevalence rises, existing treatments remain limited in efficacy, necessitating... ...